The ground-breaking prognostic test that can predict the onset of diabetic kidney disease and future kidney function decline in patients with type 2 diabetes.
Diabetic kidney disease is the leading cause of chronic and end-stage kidney disease worldwide¹. Most people with diabetic kidney disease do not have symptoms². Prevention is better than cure – transform clinical outcomes.
17th September 2021 - PromarkerD at EASD
12th August 2021 - Proteomics International Laboratories (ASX:PIQ) contracts Biotem to manufacture test kits – The Market Herald
12th August 2021 - Proteomics International contracts Biotem to manufacture PromarkerD test kits
11th August 2021 - Diabetes treatment lowers PromarkerD risk score: Results presented at Australasian Diabetes Congress
“PromarkerD will save lives and healthcare costs” – Dr Richard Lipscombe to American Diabetes Association (ADA) TV